Published in J Virol on June 01, 1988
Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A (2008) 2.43
Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J (1988) 2.13
Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J (1991) 1.87
Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J Virol (1993) 1.68
Mutational analysis of the core, spacer, and initiator regions of vaccinia virus intermediate-class promoters. J Virol (1992) 1.50
Characterization of the single-stranded DNA binding protein encoded by the vaccinia virus I3 gene. J Virol (1998) 1.50
Transcriptional mapping and nucleotide sequence of a vaccinia virus gene encoding a polypeptide with extensive homology to DNA ligases. Nucleic Acids Res (1989) 1.43
Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. J Virol (1989) 1.40
Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro. J Virol (1990) 1.25
M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies. J Virol (1989) 1.24
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Infect Immun (1996) 1.20
The vaccinia virus I1 protein is essential for the assembly of mature virions. J Virol (1997) 1.17
Structure and expression of the vaccinia virus gene which prevents virus-induced breakdown of RNA. J Virol (1990) 1.12
Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities. Proc Natl Acad Sci U S A (1992) 1.11
Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. Future Microbiol (2010) 1.07
In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes. Vaccine (2009) 1.05
Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis. PLoS Pathog (2010) 1.03
Deoxyadenosine reverses hydroxyurea inhibition of vaccinia virus growth. J Virol (1991) 0.99
Protection of mice and swine from pseudorabies virus conferred by vaccinia virus-based recombinants. J Virol (1992) 0.99
Identification, cloning, and sequencing of a fragment of Amsacta moorei entomopoxvirus DNA containing the spheroidin gene and three vaccinia virus-related open reading frames. J Virol (1991) 0.98
Vaccinia virus encodes a thymidylate kinase gene: sequence and transcriptional mapping. Nucleic Acids Res (1989) 0.97
Vaccinia virus intermediate and late promoter elements are targeted by the TATA-binding protein. J Virol (2006) 0.92
Acidic C terminus of vaccinia virus DNA-binding protein interacts with ribonucleotide reductase. Proc Natl Acad Sci U S A (1993) 0.90
Transcription of a poxvirus early gene is regulated both by a short promoter element and by a transcriptional termination signal controlling transcriptional interference. J Virol (1989) 0.89
Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression. J Virol (1989) 0.87
A cellular protein binds vaccinia virus late promoters and activates transcription in vitro. J Virol (1998) 0.79
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
Rapid and sensitive protein similarity searches. Science (1985) 76.83
A new pair of M13 vectors for selecting either DNA strand of double-digest restriction fragments. Gene (1982) 59.01
Enhanced graphic matrix analysis of nucleic acid and protein sequences. Proc Natl Acad Sci U S A (1981) 46.11
Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs. Nucleic Acids Res (1984) 39.52
Prediction of protein antigenic determinants from amino acid sequences. Proc Natl Acad Sci U S A (1981) 32.98
DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature (1984) 27.05
Expression of the Rous sarcoma virus pol gene by ribosomal frameshifting. Science (1985) 5.90
Methylated nucleotides block 5'-terminus of vaccinia virus messenger RNA. Proc Natl Acad Sci U S A (1975) 5.16
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell (1981) 4.42
Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5' poly(A) leader. Cell (1987) 3.31
Cell-free translation of early and late mRNAs selected by hybridization to cloned DNA fragments derived from the left 14 million to 72 million daltons of the vaccinia virus genome. Virology (1981) 3.10
Regulation of expression and nucleotide sequence of a late vaccinia virus gene. J Virol (1984) 2.84
Primary structure of the Escherichia coli ribonucleoside diphosphate reductase operon. Proc Natl Acad Sci U S A (1984) 2.54
Arrangement of late RNAs transcribed from a 7.1-kilobase EcoRI vaccinia virus DNA fragment. J Virol (1984) 2.48
Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J (1986) 2.41
Vaccinia virus produces late mRNAs by discontinuous synthesis. Cell (1987) 2.26
Nucleotide sequence and genetic map of the 16-kb vaccinia virus HindIII D fragment. Virology (1986) 2.25
Restriction enzyme mapping of vaccinia virus DNA. J Virol (1982) 2.15
Nucleotide sequence of a cluster of early and late genes in a conserved segment of the vaccinia virus genome. Nucleic Acids Res (1985) 2.02
Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence. Cell (1986) 2.02
Multiple 3' ends of mRNA encoding vaccinia virus growth factor occur within a series of repeated sequences downstream of T clusters. J Virol (1986) 1.40
Vaccinia virus-encoded ribonucleotide reductase: sequence conservation of the gene for the small subunit and its amplification in hydroxyurea-resistant mutants. J Virol (1988) 1.23
Noncoordinate regulation of a vaccinia virus late gene cluster. J Virol (1987) 0.96
Rapid and efficient purification of native histidine-tagged protein expressed by recombinant vaccinia virus. Proc Natl Acad Sci U S A (1991) 3.57
Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini. Cell (1983) 3.36
Discontinuous transcription or RNA processing of vaccinia virus late messengers results in a 5' poly(A) leader. Cell (1987) 3.31
RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J (1992) 3.03
A central role for P48/45 in malaria parasite male gamete fertility. Cell (2001) 2.73
Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J (1994) 2.62
Conserved TAAAT motif in vaccinia virus late promoters: overlapping TATA box and site of transcription initiation. EMBO J (1986) 2.41
Heterodimerization of the Drosophila ecdysone receptor with retinoid X receptor and ultraspiracle. Nature (1993) 2.15
Derepression of a novel class of vaccinia virus genes upon DNA replication. EMBO J (1988) 2.13
TFIID is required for in vitro transcription of the human U6 gene by RNA polymerase III. EMBO J (1991) 1.97
The nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the C-terminal hyperacidic tail which is essential for transactivation. EMBO J (1992) 1.94
Vaccinia virus capping enzyme is a transcription initiation factor. EMBO J (1991) 1.87
Bioassay for components regulating eukaryotic gene expression: a chromosomal factor involved in the generation of histone mRNA 3' termini. Proc Natl Acad Sci U S A (1982) 1.77
Improved method for PCR-mediated site-directed mutagenesis. Nucleic Acids Res (1994) 1.70
UTF1, a novel transcriptional coactivator expressed in pluripotent embryonic stem cells and extra-embryonic cells. EMBO J (1998) 1.65
Functional characterization of a natural retinoic acid responsive element. EMBO J (1991) 1.63
Vaccinia virus late transcripts generated in vitro have a poly(A) head. EMBO J (1988) 1.58
Affinity purification of histidine-tagged proteins. Mol Biol Rep (1993) 1.57
Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A. Cell (1992) 1.50
Promoter melting by a stage-specific vaccinia virus transcription factor is independent of the presence of RNA polymerase. Cell (1991) 1.47
Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J (1993) 1.45
Identification of multiple SRF N-terminal phosphorylation sites affecting DNA binding properties. EMBO J (1992) 1.44
Cis-acting sequences affecting the length of the poly(A) head of vaccinia virus late transcripts. Nucleic Acids Res (1988) 1.35
Isolation and functional characterization of two distinct sexual-stage-specific promoters of the human malaria parasite Plasmodium falciparum. Mol Cell Biol (1999) 1.34
9-cis retinoic acid signaling: changing partners causes some excitement. Genes Dev (1995) 1.25
Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro. J Virol (1990) 1.25
BS69, a novel adenovirus E1A-associated protein that inhibits E1A transactivation. EMBO J (1995) 1.21
Monoclonal antibodies directed against the amino-terminal domain of human TBP cross-react with TBP from other species. Hybridoma (1996) 1.18
Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells. Nature (1993) 1.16
The Mad1-Sin3B interaction involves a novel helical fold. Nat Struct Biol (2000) 1.11
TAC, a TBP-sans-TAFs complex containing the unprocessed TFIIAalphabeta precursor and the TFIIAgamma subunit. Mol Cell (2000) 1.09
Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer. Genes Dev (1994) 1.05
Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. EMBO J (1998) 0.97
Assembly and DNA binding of recombinant Ku (p70/p80) autoantigen defined by a novel monoclonal antibody specific for p70/p80 heterodimers. J Cell Sci (1994) 0.96
Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family. J Biol Chem (1995) 0.94
Assembly and expression of a synthetic gene encoding the antigen Pfs48/45 of the human malaria parasite Plasmodium falciparum in yeast. Vaccine (2000) 0.94
De novo transcriptome characterization and development of genomic tools for Scabiosa columbaria L. using next-generation sequencing techniques. Mol Ecol Resour (2011) 0.91
The glucocorticoid receptor hormone binding domain mediates transcriptional activation in vitro in the absence of ligand. Nucleic Acids Res (1993) 0.90
Genome-wide functions of PML-RARα in acute promyelocytic leukaemia. Br J Cancer (2011) 0.89
Avian erythroleukemia: a model for corepressor function in cancer. Oncogene (2001) 0.88
RNA polymerase from the fungus, Aspergillus nidulans. Large-scale purification of DNA-dependent RNA polymerase I (or A). Eur J Biochem (1979) 0.88
Human androgen receptor expressed in HeLa cells activates transcription in vitro. Nucleic Acids Res (1994) 0.87
Thyroid hormone-dependent transcriptional repression of neural cell adhesion molecule during brain maturation. EMBO J (1996) 0.85
Targeting of frog prodermorphin to the regulated secretory pathway by fusion to proenkephalin. J Cell Biol (1991) 0.84
The promoter context is a decisive factor in establishing selective responsiveness to nuclear class II receptors. EMBO J (1997) 0.84
Yeast TBP can replace its human homologue in the RNA polymerase I-specific multisubunit factor SL1. J Mol Biol (1994) 0.84
An alpha-amanitin-resistant DNA-dependent RNA polymerase II from the fungus Aspergillus nidulans. Eur J Biochem (1981) 0.83
Retinoid-dependent transcription: the RAR/RXR-TBP-EIA/EIA-LA connection. Biochem Soc Symp (1996) 0.83
Requirement of cofactors for RXR/RAR-mediated transcriptional activation in vitro. Biochim Biophys Acta (1997) 0.83
Cloning and expression of a mouse cDNA encoding p59, an immunophilin that associates with the glucocorticoid receptor. Gene (1993) 0.83
Sequence-specific assignment of the PAH2 domain of Sin3B free and bound to Mad1. J Biomol NMR (2001) 0.81
Retinoid-dependent in vitro transcription. Methods Enzymol (1996) 0.80
Differential binding and transcriptional behaviour of two highly related orphan receptors, ROR alpha(4) and ROR beta(1). Biochim Biophys Acta (2000) 0.79
Protoplasts from Aspergillus nidulans. Microbios (1979) 0.78
The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer. Oncogene (2001) 0.77
Retinoic acid posttranscriptionally up-regulates proteolipid protein gene expression in C6 glioma cells. J Biol Chem (1993) 0.77
Depletion in nuclei of proteins associated with hnRNA, as a result of inhibition of RNA synthesis. Exp Cell Res (1978) 0.77
Differential transcription of the orphan receptor RORbeta in nuclear extracts derived from Neuro2A and HeLa cells. Nucleic Acids Res (2001) 0.76
Effect of alpha-amanitin and actinomycin D on RNA synthesis in the protoplasts of Aspergillus nidulans. Microbios (1982) 0.75